New Delaware Marijuana Commissioner Takes Helm
Delaware’s marijuana commissioner role has a new face at a crucial moment. Cannabis attorney and lobbyist Joshua Sanderlin has officially been appointed to lead the state’s cannabis program, stepping in as adult-use sales face early delays and rising pressure from stakeholders.
With the spring 2025 launch window for recreational marijuana sales already pushed back, Sanderlin steps into a high-pressure role: guiding Delaware‘s emerging market toward safe, structured, and transparent rollout—all while public interest and political scrutiny intensify.
Key Takeaways
- Delaware has confirmed Joshua Sanderlin, a D.C.-based cannabis attorney, as its new marijuana commissioner.
- Sanderlin replaces Robert Coupe, who resigned in January 2024.
- The state’s recreational cannabis launch has been delayed due to FBI fingerprinting and background check bottlenecks.
- Conditional licenses will be issued once background checks are cleared, but licenses must be activated within 18 months.
- Leadership has pledged to build a cannabis market that prioritizes public safety, access, and regulatory integrity.
Delaware’s Marijuana Commissioner Has Industry Roots
Sanderlin is the founder of Sanderlin Strategies, a Washington, D.C.-based firm specializing in cannabis law, regulatory compliance, and government affairs. His background includes helping cannabis companies navigate complex legal environments—a skill set that Gov. Matt Meyer praised when nominating him in April.
“His experience navigating complex regulatory systems and work across the cannabis industry make him uniquely qualified to launch Delaware’s adult-use marijuana market quickly and correctly,” Meyer said.
“With Josh at the helm, we’re ready to build a system that is safe, transparent, and delivers real opportunity for hardworking Delawareans.”
Sanderlin replaces Robert Coupe, Delaware’s first marijuana commissioner, who stepped down earlier this year. Deputy Commissioner Paul Hyland served as acting head of the office during the transition.
Market Stalled by Fingerprinting Delays
Although Delaware’s adult-use legalization law passed in 2023, the state has yet to issue licenses or open retail operations. A spring 2025 start was originally targeted, but that timeline has since been derailed due to processing delays at the federal level.
The FBI’s fingerprinting backlog has slowed down critical background checks required for prospective cannabis business licensees. As a result, conditional license approvals remain paused, and applicants are left in limbo while the state works through the bottleneck.
| Step | Current Status | Timeline Impact |
|---|---|---|
| FBI Fingerprinting | Severe delay | Launch window missed |
| Background Verification | Still pending for many | Several months behind |
| Conditional Licenses | Awaiting clearances | On hold |
| Business Openings | Must occur within 18 months | Else license is revoked |
Sanderlin now holds the authority to begin awarding conditional licenses once applicants clear the federal background process. Under Delaware law, these licenses will only remain valid if the business opens within 18 months of approval.
Shaping a Market with Transparency and Control
Delaware’s marijuana commissioner is seen by many advocates and business owners as a move toward greater regulatory clarity and professionalism. Sanderlin is tasked with designing and enforcing the rules for product safety, marketing, retail operations, equity participation, and more.
The commissioner’s stated priorities include:
- Building a well-regulated adult-use cannabis program
- Ensuring public safety and product quality
- Supporting entrepreneurship and access, especially for local applicants
- Maintaining transparency and fairness throughout licensing
For a state just beginning to implement legal adult-use cannabis, these priorities will shape not just policy, but public trust.
Conclusion
The appointment of Joshua Sanderlin as Delaware’s marijuana commissioner comes at a pivotal time for the state’s cannabis industry. With recreational sales already delayed and pressure mounting from stakeholders eager to enter the market, Sanderlin’s legal expertise and cannabis policy background position him as a steady hand in a complex moment.
Whether Delaware can hit its updated targets and deliver on its promise of a safe, fair, and transparent cannabis market will depend in part on how quickly Sanderlin and his team can cut through red tape—and how well they can balance public interest with business opportunity.


Responses